Eli Lilly and Company · 22 hours ago
Senior Director - Acquisitions Integration Lead
Eli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, committed to making life better for people around the world. The Senior Director, Acquisitions Integration Lead will be responsible for formulating integration strategies for new acquisitions, managing stakeholder alignment, and leading cross-functional integration planning and execution.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Participate in technical and corporate due diligence and the transaction deal team processes to inform integration strategy and planning
Develop acquisition integration strategies including operating model and people strategy, define integration priorities based on risks from diligence and business objectives, and gain alignment with Sr. Leadership
Create acquisition transition roadmap to drive alignment and optimize transparency among leaders and target company employees during integration planning & execution
Develop comprehensive integration plans, including timelines & resource allocation (in partnership with HR)
Lead integration meetings and coordinate activities and dependencies across functions – ensuring functions remain properly informed of priorities
Track and report integration progress aligned with the established KPIs
Identify TA Business Lead, Program Management Lead (COO) and other key functional leads to support the integration
Establish governance and responsibilities related to decision-making
Resolve major issues and proactively manage risks, while rapidly escalating any issues that cannot be quickly resolved
Build and maintain contacts with key stakeholders and decision makers in the TA and functional areas
Drive continuous improvement to strengthen the ATT brand and increase efficiency and consistency across acquisitions
Seek to understand and represent the needs of the acquired companies. Timely and effectively communicate to and influence relevant stakeholders and decision makers
Coach and develop team members and others within and outside the organization to effectively develop talent and establish succession plan for key roles
Foster a collaborative, positive and inclusive work environment
Qualification
Required
Bachelor's degree required
10+ years of experience in the biopharmaceutical industry with drug discovery and development processes and/or providing hands-on integration consultation support within the biopharmaceutical industry
Preferred
MS, MBA, PhD, PharmD preferred
Experience leading whole company integrations of various sizes and complexity, including OUS
Experience developing transition services agreements and/or leading asset acquisitions from external companies
Exceptional project management skills, with a track record of successfully managing complex projects
Strong working knowledge of due diligence and business development transaction processes
Outstanding EQ, strong business acumen, strategic thinking, and problem-solving capabilities
Experience working collaboratively with external companies
Excellent communication and interpersonal skills to effectively engage with stakeholders at all levels, both internally and externally
Change management expertise, with the ability to navigate organizational transitions
Highly self-motivated and organized; able to multitask with concurrent processing and implementation of many active programs at various stages of evaluation and business discussions
Strategic negotiation and relationship management experience
An understanding of industry trends and best practices related to M&A integrations
Benefits
Company bonus
Company-sponsored 401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
Recent News
The Motley Fool
2026-01-25
2026-01-24
2026-01-23
Company data provided by crunchbase